Genome Editing Market Booming with CRISPR & AI-Driven Precision, Projected to Hit US$ 37.22 Billion by 2033 | Top Companies 2025 - Medtronic Inc., Becton Dickinson & Company, Baxter International Inc.

"Genome Editing Market reached US$ 9.50 Billion in 2024 and is expected to reach US$ 37.22 Billion by 2033, growing at a CAGR of 16.5% during the forecast period 2025-2033." As per DataM intelligence research report

Market growth opportunities(2025-2031):

Genome Editing in the US and Japan offers expanding opportunities in gene therapy, agricultural biotech, and microbiome engineering as patient demand for precision treatment grows. Genome Editing benefits from integrated AI design tools and regulatory pathways facilitating clinical translation. In Japan, government and SIP‐funded initiatives support crop, fish, and microbial genome editing for food security and environmental applications. In the US, partnerships between nanoparticle delivery firms and CRISPR developers enable personalized therapies. Genome Editing adoption aligns with rising chronic disease burden and regenerative medicine needs. Collaboration between academia, biotech startups, and CDMOs accelerates R&D pipelines. Genome Editing platforms offering safer, multiplexed editing and modular design are gaining traction across both national markets.

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/genome-editing-market?sp

Genome Editing Market: Recent Industry Developments

✅In June 2025, Eli Lilly (US) finalized a $1.3 billion acquisition of Verve Therapeutics, which is developing CRISPR therapies targeting the PCSK9 gene for cholesterol reduction and cardiovascular disease-its lead drug enters Phase II trials

✅In May 2025, Acuitas Therapeutics (US/Canada) successfully delivered the first personalized CRISPR therapy via lipid nanoparticles, treating a baby with rare CPS1 deficiency-representing a milestone in bespoke in vivo genome editing

✅In mid 2025, researchers at Kyushu University (Japan) reported a method of adding cytosine bases to guide RNA that improves CRISPR Cas9 cutting accuracy by 3000 fold and reduces cell death by 1800 fold, paving the way for clinical testing within about a year

Genome Editing Market: Technological Advancements

➠Researchers at Kyushu University, Japan reduced Cas9 cutting strength by adding cytosines to the guide RNA, improving targeting accuracy by ~3000× and reducing safety risks ahead of planned trials

➠At the Broad Institute/MIT, the eePASSIGE system combines prime editing with recombinases to enable insertion or replacement of entire genes efficiently-enabling large-scale gene repair

➠Profluent (US) introduced OpenCRISPR 1, an AI-designed gene editor built from scratch via generative models, demonstrating high specificity and low off-target activity in human cells

➠Yale researchers demonstrated CRISPR-Cas12a multiplex screening in mice, allowing simultaneous editing and analysis of multiple immune-related genes in a single experiment design

Strategic Players Driving the Genome Editing Market Forward:

Medtronic Inc., Becton Dickinson & Company, Baxter International Inc., Editas Medicine, Inc., Cellectis S.A., Precision BioSciences, Inc., GenScript Biotech Corporation, Lonza Group Ltd., New England Biolabs, Inc., Integrated DNA Technologies, Inc. (IDT) and among others.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/genome-editing-market?sp

Research Methodology:

The global Genome Editing Market research report employs a comprehensive dual-source approach, integrating both primary and secondary data collection methods to ensure robust market analysis. Our research framework systematically evaluates multiple industry-influencing variables, including regulatory frameworks and government policies, prevailing market conditions, competitive intensity levels, historical performance data, current market positioning, technological innovations and disruptions, emerging industry developments, cross-sector business impacts, market volatility patterns, growth prospects, potential market barriers, and strategic challenges facing industry participants.

Segment Covered in the Genome Editing Market:

➥By Technology: CRISPR/Cas9, TALENs (Transcription Activator-Like Effector Nucleases), Zinc Finger Nucleases (ZFNs), Meganucleases, Antisense Technologies, Others

➥By Delivery Method: Ex-vivo, In-vivo

➥By Application: Genetic Engineering, Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, Drug Discovery & Development, Gene-Modified Cell Therapy, Diagnostics, Others

➥By End User: Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, Contract Research Organizations (CROs)

Regional Analysis for Genome Editing Market:

The Genome Editing market is witnessing rapid growth due to advancements in CRISPR technology and rising R&D in genetic therapies. North America, especially the U.S., dominates with strong biotech investment, academic research, and clinical trial activity. Europe, including the U.K., Germany, and France, follows closely with supportive regulations and robust innovation ecosystems. Asia-Pacific, particularly China, Japan, and South Korea, is growing fast due to increasing government funding and gene therapy initiatives. South America is gradually adopting genome editing in agricultural biotech and medical research. The Middle East & Africa are emerging regions, showing potential as awareness and research infrastructure develop.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=genome-editing-market?sp

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.